These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 35704319)
1. Analysis of Lung Cancer Screening by Race After USPSTF Expansion of Screening Eligibility in 2021. Shusted CS; Evans NR; Kane GC; Juon HS; Barta JA JAMA Netw Open; 2022 Jun; 5(6):e2217578. PubMed ID: 35704319 [TBL] [Abstract][Full Text] [Related]
2. Addressing Sex Disparities in Lung Cancer Screening Eligibility: USPSTF vs PLCOm2012 Criteria. Pasquinelli MM; Tammemägi MC; Kovitz KL; Durham ML; Deliu Z; Guzman A; Rygalski K; Liu L; Koshy M; Finn P; Feldman LE Chest; 2022 Jan; 161(1):248-256. PubMed ID: 34252436 [TBL] [Abstract][Full Text] [Related]
3. Evaluating Eligibility of US Black Women Under USPSTF Lung Cancer Screening Guidelines. Potter AL; Yang CJ; Woolpert KM; Puttaraju T; Suzuki K; Palmer JR JAMA Oncol; 2022 Jan; 8(1):163-164. PubMed ID: 34817564 [TBL] [Abstract][Full Text] [Related]
4. Risk prediction models versus simplified selection criteria to determine eligibility for lung cancer screening: an analysis of German federal-wide survey and incidence data. Hüsing A; Kaaks R Eur J Epidemiol; 2020 Oct; 35(10):899-912. PubMed ID: 32594286 [TBL] [Abstract][Full Text] [Related]
5. Potential Disparities by Sex and Race or Ethnicity in Lung Cancer Screening Eligibility Rates. Pinsky PF; Lau YK; Doubeni CA Chest; 2021 Jul; 160(1):341-350. PubMed ID: 33545164 [TBL] [Abstract][Full Text] [Related]
6. Estimating Pack-Year Eligibility for Lung Cancer Screening Using 2 Yes or No Questions. Rendle KA; Steltz JP; Cohen S; Schapira MM; Wender RC; Bekelman JE; Vachani A JAMA Netw Open; 2023 Aug; 6(8):e2327363. PubMed ID: 37548980 [TBL] [Abstract][Full Text] [Related]
7. Risk-based lung cancer screening eligibility criteria: towards implementation. Ten Haaf K Lancet Oncol; 2022 Jan; 23(1):13-14. PubMed ID: 34902333 [No Abstract] [Full Text] [Related]
9. Broadened Eligibility for Lung Cancer Screening: Challenges and Uncertainty for Implementation and Equity. Henderson LM; Rivera MP; Basch E JAMA; 2021 Mar; 325(10):939-941. PubMed ID: 33687453 [No Abstract] [Full Text] [Related]
10. Risk Prediction Model Versus United States Preventive Services Task Force Lung Cancer Screening Eligibility Criteria: Reducing Race Disparities. Pasquinelli MM; Tammemägi MC; Kovitz KL; Durham ML; Deliu Z; Rygalski K; Liu L; Koshy M; Finn P; Feldman LE J Thorac Oncol; 2020 Nov; 15(11):1738-1747. PubMed ID: 32822843 [TBL] [Abstract][Full Text] [Related]
11. Time to quit using quit time as a lung cancer screening eligibility criterion. Tammemägi MC Cancer; 2024 Jan; 130(2):182-185. PubMed ID: 37658650 [No Abstract] [Full Text] [Related]
12. Estimating eligibility for lung cancer screening in an Australian cohort, including the effect of spirometry. Manners D; Hui J; Hunter M; James A; Knuiman MW; McWilliams A; Mulrennan S; Musk AW; Brims FJ Med J Aust; 2016 Jun; 204(11):406. PubMed ID: 27318396 [TBL] [Abstract][Full Text] [Related]
13. Ethical implications of changing the eligibility criteria for the proposed National Lung Cancer Screening Program. Ryan JB Med J Aust; 2023 Aug; 219(4):187. PubMed ID: 37517815 [No Abstract] [Full Text] [Related]
14. Age, Sex, Smoking, and Race: Is Progress Being Made in Lung Cancer Screening Eligibility? Sears CR; Rivera MP Chest; 2021 Jul; 160(1):31-33. PubMed ID: 34246372 [No Abstract] [Full Text] [Related]
15. Re: Inaccuracies in electronic health records smoking data and a potential approach to address resulting underestimation in determining lung cancer screening eligibility. Kukhareva P; Caverly T; Kawamoto K J Am Med Inform Assoc; 2022 Aug; 29(9):1655. PubMed ID: 35822406 [No Abstract] [Full Text] [Related]
16. Re: Inaccuracies in electronic health records smoking data and a potential approach to address resulting underestimation in determining lung cancer screening eligibility. Tarabichi Y; Thornton JD J Am Med Inform Assoc; 2022 Aug; 29(9):1654. PubMed ID: 35822414 [No Abstract] [Full Text] [Related]
17. Estimating Eligibility for Lung Cancer Screening by Neighborhood in Philadelphia Using Previous and Current USPSTF Guidelines. McIntire RK; Lewis E; Zeigler-Johnson C; Shusted C; Barta J; Juon HS; Keith SW; Klein G Popul Health Manag; 2022 Apr; 25(2):254-263. PubMed ID: 35442796 [TBL] [Abstract][Full Text] [Related]
18. Model-Based Eligibility for Lung Cancer Screening: Where Theory Meets Practice. Green AK; Bach P Ann Intern Med; 2018 Feb; 168(3):223-224. PubMed ID: 29297001 [No Abstract] [Full Text] [Related]
19. Assessment of Biomarker Testing for Lung Cancer Screening Eligibility. Larose TL; Meheus F; Brennan P; Johansson M; Robbins HA JAMA Netw Open; 2020 Mar; 3(3):e200409. PubMed ID: 32134462 [TBL] [Abstract][Full Text] [Related]
20. Stratification and management of patients ineligible for lung cancer screening. Aggarwal R; Lam AC; Huang J; Hueniken K; Nguyen D; Khan K; Shaikh T; Shepherd FA; Tsao MS; Xu W; Kavanagh J; Liu G Respir Med; 2021 Nov; 188():106610. PubMed ID: 34592536 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]